These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20172932)

  • 1. Investigation of biokinetics of radioiodine with a population kinetics approach.
    Janzen T; Giussani A; Canzi C; Gerundini P; Oeh U; Hoeschen C
    Radiat Prot Dosimetry; 2010; 139(1-3):232-5. PubMed ID: 20172932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.
    Canzi C; Zito F; Voltini F; Reschini E; Gerundini P
    Med Phys; 2006 Aug; 33(8):2860-7. PubMed ID: 16964862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves' disease.
    van Isselt JW; Broekhuizen-de Gast HS
    Hell J Nucl Med; 2010; 13(1):2-5. PubMed ID: 20411161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity application.
    Reinartz P; Zimny M; Schaefer W; Mueller B; Buell U; Sabri O
    Nucl Med Commun; 2003 Dec; 24(12):1247-53. PubMed ID: 14627852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid echogenicity: A clue to precise individual dosimetry in radioiodine therapy of hyperthyroidism.
    Marković V; Eterović D; Stipanović P; Punda A
    Med Hypotheses; 2011 Feb; 76(2):153-6. PubMed ID: 20889262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign thyroid disease: what is the role of nuclear medicine?
    Sarkar SD
    Semin Nucl Med; 2006 Jul; 36(3):185-93. PubMed ID: 16762609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
    Nüchel C; Boddenberg B; Schicha H
    Nuklearmedizin; 1993 Apr; 32(2):91-8. PubMed ID: 8479936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of radioiodine uptake in hyperthyroidism by administration of hydrochlorothiazide.
    Walter MA; Nitzsche EU; Müller-Brand J
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):474. PubMed ID: 12634976
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized radioiodine therapy for Graves' disease: two MIRD-based models for the computation of patient-specific therapeutic 131I activity.
    Carlier T; Salaun PY; Cavarec MB; Valette F; Turzo A; Bardiès M; Bizais Y; Couturier O
    Nucl Med Commun; 2006 Jul; 27(7):559-66. PubMed ID: 16794516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving individualised dosimetry in radioiodine therapy for hyperthyroidism using population biokinetic modelling.
    Melgar Pérez J; Orellana Salas A; Santaella Guardiola Y; Antoranz Callejo JC
    Phys Med; 2019 Jun; 62():33-40. PubMed ID: 31153396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperthyroidism--diagnosis and treatment. Indications and contraindications for radioiodine therapy.
    Gurgul E; Sowinski J
    Nucl Med Rev Cent East Eur; 2011; 14(1):29-32. PubMed ID: 21751169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Computer analysis system for scintigraphic imaging of the thyroid in patients with hyperthyroidism treated with radioiodine].
    Dyszkiewicz A; Kucharz EJ
    Pol Arch Med Wewn; 2002 Jan; 107(1):45-52. PubMed ID: 12046343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
    Melo DR; Brill AB; Zanzonico P; Vicini P; Moroz B; Kwon D; Lamart S; Brenner A; Bouville A; Simon SL
    Radiat Res; 2015 Dec; 184(6):595-610. PubMed ID: 26579944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism.
    Okosieme OE; Chan D; Price SA; Lazarus JH; Premawardhana LD
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):122-7. PubMed ID: 19453641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy for treatment of hyper- and hypofunctioning thyroid nodules.
    Happel C; Korkusuz H; Kranert WT; Grünwald F
    Nuklearmedizin; 2014; 53(6):N48-9. PubMed ID: 25483112
    [No Abstract]   [Full Text] [Related]  

  • 18. Feline hyperthyroidism. The contribution of nuclear medicine.
    Lass P; Kaniuka S
    Hell J Nucl Med; 2005; 8(3):145-8. PubMed ID: 16390018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific dosimetry for radioiodine therapy of the autonomous thyroid nodule.
    Matheoud R; Canzi C; Reschini E; Zito F; Voltini F; Gerundini P
    Med Phys; 2003 May; 30(5):791-8. PubMed ID: 12772986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
    Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.